SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-23-001787
Filing Date
2023-02-23
Accepted
2023-02-23 18:03:01
Documents
2
Period of Report
2023-02-21

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 9191
2 KIMI IGUCHI POA 2019 kimiiguchipoa2019.txt EX-24 2125
  Complete submission text file 0001562180-23-001787.txt   12648
Mailing Address 100 FOXBOROUGH BOULEVARD SUITE 240 FOXBOROUGH MA 02035
Business Address
IGUCHI KIMI (Reporting) CIK: 0001304815 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36544 | Film No.: 23661429

Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Issuer) CIK: 0001597553 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences